The Construction of a Prognostic Model Based on a Peptidyl Prolyl Cis–Trans Isomerase Gene Signature in Hepatocellular Carcinoma

por Huadi Shi, Fulan Zhong, Xiaoqiong Yi, Zhenyi Shi, Feiyan Ou, Yufang Zuo, Zumin Xu
Publicado 2021

<i>CSMD1</i> Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer

por Taobi Huang, Yuan Liang, Huiyun Zhang, Xia Chen, Hui Wei, Weiming Sun, Yuping Wang
Publicado 2021